{{Rsnum
|rsid=9544105
|Chromosome=13
|position=75984017
|Orientation=plus
|GMAF=0.1662
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 41.6 | 50.4
| HCB | 0.0 | 18.2 | 81.8
| JPT | 1.8 | 18.6 | 79.6
| YRI | 0.0 | 5.4 | 94.6
| ASW | 0.0 | 7.0 | 93.0
| CHB | 0.0 | 18.2 | 81.8
| CHD | 2.8 | 19.3 | 78.0
| GIH | 5.9 | 32.7 | 61.4
| LWK | 0.0 | 1.8 | 98.2
| MEX | 1.7 | 24.1 | 74.1
| MKK | 0.0 | 10.3 | 89.7
| TSI | 9.8 | 43.1 | 47.1
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs9544105
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363827
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9544105
|overall_frequency_n=18
|overall_frequency_d=126
|overall_frequency=0.142857
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=11
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}